🔥Telegram İfşa

Read in #npjVaccines how @PamelaTWong, Michael Schotsaert et al. rationally designed a combined mucosal adjuvant that induces robust protective humoral, cellular, and mucosal immunity against SARS-CoV-2 in young and senescent mice. go.nature.com/44bS9nW

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

WHO recommends R21/Matrix-M vaccine for #malaria prevention in updated advice on immunization bit.ly/46b4F8f

Compartir espacio con Coppola es una de esas cosas increíbles que tiene el periodismo. elpais.com/economia/negoc… via EL PAÍS

Hablé con el CEO de Moderna sobre el Nobel, las vacunas, restaurar coches y desconectar del trabajo. Por cierto, es más de llevar Ibuprofeno que de pedírselo a alguien en la oficina. elpais.com/economia/negoc… via EL PAÍS

We shared this before as preprint - now published in #PLOSPathogens: Breakthrough infections by #SARSCoV2 variants boost cross-reactive hybrid immune responses in mRNA vaccinated hamsters dx.plos.org/10.1371/journa…. Grad School at Icahn Mount Sinai Icahn Genomics Institute Lipschultz Precision Immunology Institute #SinaiVirology

No te pierdas el capítulo que hemos escrito sobre Schistosoma y schistosomiasis (Chapter 164: doi.org/10.1016/B978-0…) en el libro Molecular Medical Microbiology (Third Edition) 2024; sciencedirect.com/book/978012818…. Grupo e-INTRO, IBSAL

This makes my day. You’re looking at very very good T cell activation… Congrats Team! ⁦Icahn School of Medicine at Mount Sinai⁩ ⁦Grad School at Icahn Mount Sinai⁩

Premio extraordinario de doctorado de la Universidad de Salamanca para tres de nuestros alumnos del grupo e-INTRO (Enfermedades Infecciosas y Tropicales)-IBSAL y CIETUS. Magnífico trabajo.

Join us for the Biotech-Biopharma Summit next Thursday, the 27th, from 4 PM to 7 PM! Dive into how technology is already shaping the future of medicine! Few spots still available! Register #SalamancaTechSummit #PACBB2024 Universidad de Salamanca #salamanca

Controlled experimental infections with #Schistosoma mansoni reveal how the human #immune response to #schistosomiasis changes over time. Read this research and more in the July issue of Science #Immunology: scim.ag/7zC

🙋‍♂️Another collaborative paper is out in Travel Medicine and Infectious Diseases. Impact of species hybridization on the clinical management of schistosomiasis: a prospective study. sciencedirect.com/science/articl… Thanks to Medicina Tropical Hospital de Poniente, Universitat València and e-INTRo group of IBSAL .

Reciente el Capítulo 34 'Nucleic Acid Diagnostics' en el libro Handbook of Molecular Biotechnology doi.org/10.1201/978100… This chapter hopes to draw readers' attention to the necessity to develop and increase availability of portable, fast and easy-to-use diagnostic tools.

Happy to share our work just published in Nature Communications! We investigate the differential role of prior SARS-CoV-2 and influenza exposure in the outcome of SARS-CoV-2 reinfections, depending on mouse genetic background. Amazing teamwork from Michael Schotsaert lab nature.com/articles/s4146…

Our latest manuscript describing a preclinical model for #SARSCoV2 and #influenza #reinfection is out. #Macrophage responses rather than lymphocytes may drive the differences in disease outcome. Lipschultz Precision Immunology Institute #SinaiMicro Grad School at Icahn Mount Sinai. nature.com/articles/s4146…

Ever wondered how gut microbes control immune responses at extra-intestinal locations? Here, #theonlylabever reports how a gut protozoan commensal microbe remotely shapes pulmonary immunity to exacerbate asthma and limit the dissemination of mycobacteria. Cell ⬇️(1/X)

🥳 Nochevieja desde la redacción | 'Cosas cursis para cuando ya no sea Navidad', la opinión de Selina ow.ly/HJMH50UyfCM

A new Science #Immunology Review discusses how #vaccine #adjuvants function and highlight knowledge gaps that need to be addressed to develop improved vaccines against emerging pathogens. Koch Institute at MIT MIT Dept of BE Scripps Research scim.ag/430weCB